Royalty Pharma plc (RPRX)
USD 32.29
(1.06%)
USD 32.29
(1.06%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.49 Billion USD | 52.65% |
| 2022 | 977.49 Million USD | -31.68% |
| 2021 | 1.43 Billion USD | -10.3% |
| 2020 | 1.59 Billion USD | -39.2% |
| 2019 | 2.62 Billion USD | 92.25% |
| 2018 | 1.36 Billion USD | 45.2% |
| 2017 | 939.69 Million USD | 29.99% |
| 2016 | 722.87 Million USD | -8.99% |
| 2015 | 794.27 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -73.77 Million USD | -112.03% |
| 2024 Q2 | 269.63 Million USD | 465.48% |
| 2023 Q1 | 478.97 Million USD | 402.39% |
| 2023 Q4 | 613 Million USD | 304.78% |
| 2023 Q2 | 248.84 Million USD | -48.05% |
| 2023 FY | 1.49 Billion USD | 52.65% |
| 2023 Q3 | 151.44 Million USD | -39.14% |
| 2022 FY | 977.49 Million USD | -31.68% |
| 2022 Q4 | 95.33 Million USD | -50.4% |
| 2022 Q3 | 192.21 Million USD | -15.56% |
| 2022 Q2 | 227.64 Million USD | 3.61% |
| 2022 Q1 | 219.71 Million USD | 43.22% |
| 2021 Q3 | 303.05 Million USD | -59.32% |
| 2021 Q4 | 153.41 Million USD | -49.38% |
| 2021 Q1 | 229.29 Million USD | -26.98% |
| 2021 FY | 1.43 Billion USD | -10.3% |
| 2021 Q2 | 744.94 Million USD | 224.88% |
| 2020 Q3 | 511 Million USD | 24.83% |
| 2020 Q1 | 361.43 Million USD | -72.86% |
| 2020 FY | 1.59 Billion USD | -39.2% |
| 2020 Q4 | 314 Million USD | -38.55% |
| 2020 Q2 | 409.34 Million USD | 13.26% |
| 2019 Q1 | 430.9 Million USD | 0.0% |
| 2019 FY | 2.62 Billion USD | 92.25% |
| 2019 Q4 | 1.33 Billion USD | 150.13% |
| 2019 Q3 | 532.49 Million USD | 62.42% |
| 2019 Q2 | 327.85 Million USD | -23.91% |
| 2018 FY | 1.36 Billion USD | 45.2% |
| 2017 FY | 939.69 Million USD | 29.99% |
| 2016 FY | 722.87 Million USD | -8.99% |
| 2015 FY | 794.27 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Agenus Inc. | -159.54 Million USD | 1035.23% |
| Immix Biopharma, Inc. | -16.14 Million USD | 9344.406% |
| Keros Therapeutics, Inc. | -169.94 Million USD | 978.04% |
| Caribou Biosciences, Inc. | -116.05 Million USD | 1385.682% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 492.159% |
| MiMedx Group, Inc. | 37.11 Million USD | -3920.234% |
| Novavax, Inc. | -566.51 Million USD | 363.393% |
| Seer, Inc. | -103.46 Million USD | 1542.206% |
| Acelyrin, Inc. | -422.06 Million USD | 453.536% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | 3490.479% |
| IO Biotech, Inc. | -91.44 Million USD | 1731.782% |
| Ardelyx, Inc. | -63.27 Million USD | 2458.161% |
| C4 Therapeutics, Inc. | -139.03 Million USD | 1173.25% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | 3410.203% |
| Fortress Biotech, Inc. | -142.34 Million USD | 1148.285% |
| Fortress Biotech, Inc. | -142.34 Million USD | 1148.285% |
| Geron Corporation | -193.94 Million USD | 869.372% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | 827.871% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | 1627.371% |
| Incyte Corporation | 620.52 Million USD | -140.466% |
| Innoviva, Inc. | 176.7 Million USD | -744.411% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | 17652.641% |
| ChromaDex Corporation | -5.59 Million USD | 26750.295% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | -12394.976% |
| MEI Pharma, Inc. | 14.54 Million USD | -10160.968% |
| NextCure, Inc. | -67.63 Million USD | 2306.115% |
| Onconetix, Inc. | -36.03 Million USD | 4240.882% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | 3677.096% |
| GlycoMimetics, Inc. | -39.27 Million USD | 3899.208% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | 1209.991% |
| Vaxcyte, Inc. | -468.04 Million USD | 418.808% |
| Precigen, Inc. | -88.92 Million USD | 1778.025% |
| Pharming Group N.V. | -4.87 Million USD | 30679.702% |
| ContextLogic Inc. | -328 Million USD | 554.924% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | 21731.632% |
| Pyxis Oncology, Inc. | -82.19 Million USD | 1915.356% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | 7381.977% |
| AlloVir, Inc. | -181.33 Million USD | 922.887% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | 6238.866% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | 1234.844% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | 11571693.199% |
| Summit Therapeutics Inc. | -89.73 Million USD | 1762.822% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | 748.891% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | 4125.874% |
| Senti Biosciences, Inc. | -92.72 Million USD | 1709.186% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | 968.63% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | 4454.481% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | 47290.07% |
| Psyence Biomedical Ltd. | -2.75 Million USD | 54324.015% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | 2908.68% |
| Chimerix, Inc. | -93.06 Million USD | 1703.342% |
| PDS Biotechnology Corporation | -43.04 Million USD | 3566.47% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 8607.612% |
| CRISPR Therapeutics AG | -222.53 Million USD | 770.515% |
| Wave Life Sciences Ltd. | -67.99 Million USD | 2294.467% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | 991.837% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | 5114.619% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | 1642.912% |
| Precision BioSciences, Inc. | -43.73 Million USD | 3511.72% |
| Dyadic International, Inc. | -8.22 Million USD | 18231.195% |
| Elevation Oncology, Inc. | -45.44 Million USD | 3383.42% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | 125280.369% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | 3325.852% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | 628.803% |
| Aptorum Group Limited | -10.52 Million USD | 14279.447% |
| Bicycle Therapeutics plc | -189.94 Million USD | 885.565% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 37952.152% |
| Clearside Biomedical, Inc. | -24.84 Million USD | 6106.078% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | 7527.404% |
| GT Biopharma, Inc. | -13.57 Million USD | 11091.087% |
| Alkermes plc | 414.12 Million USD | -260.317% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | 2369.119% |
| Jaguar Health, Inc. | -34.29 Million USD | 4451.433% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | 4618.791% |
| AbCellera Biologics Inc. | -237.2 Million USD | 729.05% |
| PureTech Health plc | -146.19 Million USD | 1120.629% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | 7784.161% |
| Sangamo Therapeutics, Inc. | -274 Million USD | 644.57% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | 4040.294% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | 1878.19% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | 6238.866% |
| Aadi Bioscience, Inc. | -71.93 Million USD | 2174.361% |
| AnaptysBio, Inc. | -164.41 Million USD | 1007.573% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | 4508.906% |
| ESSA Pharma Inc. | -32.13 Million USD | 4743.509% |
| Molecular Templates, Inc. | -10.46 Million USD | 14357.118% |
| Scopus BioPharma Inc. | -11.71 Million USD | 12837.223% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 395.877% |
| Vaxxinity, Inc. | -58.28 Million USD | 2660.093% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | 3043.503% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | 5191.793% |
| Janux Therapeutics, Inc. | -72.97 Million USD | 2144.629% |
| Structure Therapeutics Inc. | -102.77 Million USD | 1551.861% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | 2728.922% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | 1400.088% |
| ImmuCell Corporation | -5.74 Million USD | 26059.112% |
| Lantern Pharma Inc. | -17.87 Million USD | 8446.492% |
| VYNE Therapeutics Inc. | -29.25 Million USD | 5199.973% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | 14226.195% |
| Opthea Limited | -191.84 Million USD | 877.799% |
| Avidity Biosciences, Inc. | -235.59 Million USD | 733.346% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | 1256.813% |
| Fate Therapeutics, Inc. | -190.51 Million USD | 883.236% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | 780.66% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | -1618.829% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | 2997.041% |
| Alzamend Neuro, Inc. | -9.93 Million USD | 15115.127% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | 674.658% |
| Aptose Biosciences Inc. | -52.35 Million USD | 2950.008% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | 10447.225% |
| Soligenix, Inc. | -7.69 Million USD | 19483.757% |
| Century Therapeutics, Inc. | -146.54 Million USD | 1118.213% |
| Kura Oncology, Inc. | -165.8 Million USD | 999.948% |
| TScan Therapeutics, Inc. | -93.45 Million USD | 1696.6% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | 18036.651% |
| Ocean Biomedical, Inc. | -2.48 Million USD | 60227.601% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | 23112.801% |
| Autolus Therapeutics plc | -195.02 Million USD | 865.095% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | 1862.583% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | 2125.671% |
| Eterna Therapeutics Inc. | -21.13 Million USD | 7160.09% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | 757.233% |
| GRI Bio, Inc. | -11.38 Million USD | 13203.978% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | 33143.494% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | 1237.37% |
| IGM Biosciences, Inc. | -263.46 Million USD | 666.365% |
| INmune Bio, Inc. | -29.74 Million USD | 5117.148% |
| Heron Therapeutics, Inc. | -110.61 Million USD | 1448.958% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | 4018.943% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | 9437.983% |
| Entero Therapeutics, Inc. | -15.77 Million USD | 9561.457% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | 2542.224% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | 1487.763% |
| Atara Biotherapeutics, Inc. | -276 Million USD | 640.622% |
| Coherus BioSciences, Inc. | -203.19 Million USD | 834.329% |
| Verastem, Inc. | -92.08 Million USD | 1720.423% |
| Abeona Therapeutics Inc. | -47.13 Million USD | 3265.694% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | 910.313% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | 1360.475% |
| Histogen Inc. | -10.64 Million USD | 14120.013% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | 9744.221% |
| Surrozen, Inc. | -45.78 Million USD | 3359.393% |
| Organovo Holdings, Inc. | -15.08 Million USD | 9990.959% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | 29413.965% |
| Ovid Therapeutics Inc. | -59.28 Million USD | 2617.06% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | 3009.015% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | 6002.492% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | 19649.072% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | 971.161% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | 3179.903% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | 2007.998% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | 9903.378% |
| Apollomics, Inc. | -54.83 Million USD | 2821.213% |
| Amarin Corporation plc | -67.58 Million USD | 2307.714% |
| Mesoblast Limited | -58.79 Million USD | 2637.929% |
| Turnstone Biologics Corp. | -59.03 Million USD | 2627.697% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | 1001.438% |
| Synaptogenix, Inc. | -8.31 Million USD | 18047.753% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | 10330.015% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | 1727.368% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | 31241.826% |
| Monopar Therapeutics Inc. | -8.83 Million USD | 16996.278% |
| Exelixis, Inc. | 170.88 Million USD | -773.19% |
| Better Therapeutics, Inc. | -38.26 Million USD | 3999.822% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | 1062.286% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 388.549% |
| NLS Pharmaceutics AG | -11.8 Million USD | 12737.775% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | 18654.681% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | 5074.994% |
| Gritstone bio, Inc. | -154.63 Million USD | 1064.956% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | 2266.901% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | 8814.276% |
| Avid Bioservices, Inc. | -18.67 Million USD | 8088.81% |
| Insmed Incorporated | -709.62 Million USD | 310.273% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | 9610.326% |
| MediWound Ltd. | -15.29 Million USD | 9858.993% |
| OmniAb, Inc. | -69.41 Million USD | 2249.484% |
| Alector, Inc. | -151.74 Million USD | 1083.36% |
| Seres Therapeutics, Inc. | -107.98 Million USD | 1481.838% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | 2961.375% |
| Zai Lab Limited | -366.57 Million USD | 507.054% |
| Revance Therapeutics, Inc. | -316.77 Million USD | 571.041% |
| Aura Biosciences, Inc. | -84.99 Million USD | 1855.656% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | 707.803% |
| Immunic, Inc. | -99.22 Million USD | 1603.835% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | 1142.31% |
| Veracyte, Inc. | -85.79 Million USD | 1839.204% |
| InMed Pharmaceuticals Inc. | - USD | -Infinity% |
| FibroGen, Inc. | -281.81 Million USD | 629.479% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | 10600.704% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | 21763.204% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | 8040.086% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | -157.899% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | 5962.374% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | -3745.549% |
| TG Therapeutics, Inc. | 20.63 Million USD | -7131.862% |
| Galecto, Inc. | -39.9 Million USD | 3839.256% |
| Calithera Biosciences, Inc. | -42.07 Million USD | 3646.49% |
| Fortrea Holdings Inc. | 63.1 Million USD | -2264.739% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | 1162.444% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | 5267.082% |
| XBiotech Inc. | -37.51 Million USD | 4078.006% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | 2266.901% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | 2323.108% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | 1482.824% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | 5912.364% |
| Theravance Biopharma, Inc. | -53.29 Million USD | 2899.951% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 362.145% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | 2001.022% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | 1538.785% |
| Gain Therapeutics, Inc. | -22.25 Million USD | 6805.348% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | 1826.706% |
| NexImmune, Inc. | -29.19 Million USD | 5211.419% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | 26650.088% |
| Marker Therapeutics, Inc. | -14.58 Million USD | 10333.258% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 63.13% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | 5960.992% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | 1274.348% |
| Ainos, Inc. | -13.2 Million USD | 11398.692% |
| Pluri Inc. | -22.15 Million USD | 6834.137% |
| Prothena Corporation plc | -191.03 Million USD | 881.083% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | 1180.97% |
| Celularity Inc. | -192.28 Million USD | 876.001% |
| Rallybio Corporation | -78.93 Million USD | 1990.425% |
| Cue Biopharma, Inc. | -52.14 Million USD | 2961.32% |
| MeiraGTx Holdings plc | -137.06 Million USD | 1188.676% |
| Omeros Corporation | -164.53 Million USD | 1006.917% |
| Humacyte, Inc. | -100.04 Million USD | 1591.449% |
| Immunocore Holdings plc | -59.64 Million USD | 2601.551% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | 8140.034% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | 6194.637% |
| Blueprint Medicines Corporation | -486.27 Million USD | 406.852% |
| CalciMedica, Inc. | -21.87 Million USD | 6921.257% |
| Cabaletta Bio, Inc. | -74.66 Million USD | 2098.594% |
| Scholar Rock Holding Corporation | -171.29 Million USD | 971.1% |
| Sana Biotechnology, Inc. | -326.9 Million USD | 556.455% |
| Pulmatrix, Inc. | -14.74 Million USD | 10223.134% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | 4274.43% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | 1779.101% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 389.574% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | 2308.924% |
| Cytokinetics, Incorporated | -496.2 Million USD | 400.712% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | 4435.251% |
| Nutriband Inc. | -4.87 Million USD | 30727.518% |
| Protara Therapeutics, Inc. | -43.61 Million USD | 3521.342% |
| Vor Biopharma Inc. | -126.03 Million USD | 1283.908% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 64.825% |
| Evogene Ltd. | -26.39 Million USD | 5754.011% |
| ProKidney Corp. | -151.52 Million USD | 1084.774% |
| Applied Therapeutics, Inc. | -64.53 Million USD | 2412.156% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | 19498.116% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 345.674% |
| CorMedix Inc. | -48.95 Million USD | 3147.83% |
| BioLineRx Ltd. | -49.69 Million USD | 3102.676% |
| Tango Therapeutics, Inc. | -114.17 Million USD | 1406.92% |
| Galectin Therapeutics Inc. | -38.07 Million USD | 4019.285% |
| Atai Life Sciences N.V. | -125.47 Million USD | 1289.239% |
| Renovaro Biosciences Inc. | -81.63 Million USD | 1927.735% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | 1932.905% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | 699.286% |
| Sagimet Biosciences Inc. | -30.74 Million USD | 4954.099% |
| MediciNova, Inc. | -9.9 Million USD | 15171.819% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | 1280.751% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | 20702.809% |
| GeoVax Labs, Inc. | -26.74 Million USD | 5679.604% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | 743.654% |
| Biomea Fusion, Inc. | -126.13 Million USD | 1282.979% |
| PTC Therapeutics, Inc. | -349.4 Million USD | 527.058% |
| Mereo BioPharma Group plc | -28.41 Million USD | 5351.091% |
| Cullinan Oncology, Inc. | -191.08 Million USD | 880.867% |
| Absci Corporation | -115.51 Million USD | 1391.737% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | 5508.888% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | 1422.043% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | 716.178% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | 6022.17% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | 817.401% |
| Allakos Inc. | -196.05 Million USD | 861.084% |
| Imunon, Inc. | -21.03 Million USD | 7195.195% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | 1448.361% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | -1290.867% |
| BioAtla, Inc. | -129.68 Million USD | 1250.578% |
| NLS Pharmaceutics AG | -11.8 Million USD | 12737.775% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | 9518.355% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | 555.289% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | 3673.327% |
| XOMA Corporation | -41.84 Million USD | 3665.642% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | 1517.895% |
| Cara Therapeutics, Inc. | -121.49 Million USD | 1328.158% |
| aTyr Pharma, Inc. | -54.91 Million USD | 2817.001% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | 1806.738% |
| Akero Therapeutics, Inc. | -172.87 Million USD | 963.163% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | 686.422% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | 7051.225% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | 18268.69% |
| Akari Therapeutics, Plc | -16.8 Million USD | 8978.674% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | 16873841.24% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | -342.022% |
| Lexaria Bioscience Corp. | -6.53 Million USD | 22936.623% |
| UroGen Pharma Ltd. | -65.53 Million USD | 2376.84% |
| Sutro Biopharma, Inc. | -89.27 Million USD | 1771.352% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | 20644.507% |
| Orgenesis Inc. | -53.63 Million USD | 2881.993% |
| Entera Bio Ltd. | -8.89 Million USD | 16882.702% |
| GH Research PLC | -41.22 Million USD | 3719.79% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | 5904.224% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | 1896.624% |
| Xencor, Inc. | -138.63 Million USD | 1176.284% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | 29048.025% |
| Replimune Group, Inc. | -234.77 Million USD | 735.571% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | 7043.1% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | 10794.882% |
| Lexaria Bioscience Corp. | -6.53 Million USD | 22936.623% |
| Portage Biotech Inc. | -18.25 Million USD | 8274.821% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | 20702.809% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | 1521.623% |
| OncoCyte Corporation | -25.13 Million USD | 6036.306% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | 13299.194% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | 13123.846% |
| Purple Biotech Ltd. | 22.27 Million USD | -6599.969% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | 19963.552% |
| scPharmaceuticals Inc. | -55.39 Million USD | 2793.606% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | 7995.937% |
| HilleVax, Inc. | -133.34 Million USD | 1219.015% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | 12484.015% |
| Tharimmune, Inc. | -9.45 Million USD | 15881.23% |
| Genprex, Inc. | -31.07 Million USD | 4901.682% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | 892.879% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | 4855.553% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | 195152.288% |
| Virios Therapeutics, Inc. | -5.44 Million USD | 27494.386% |
| OKYO Pharma Limited | -15.74 Thousand USD | 9474230.668% |
| Savara Inc. | -60 Million USD | 2586.627% |
| Curis, Inc. | -48.33 Million USD | 3187.292% |
| Daré Bioscience, Inc. | -30.83 Million USD | 4938.378% |
| Carmell Therapeutics Corporation | -5.21 Million USD | 28700.152% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | 20605.016% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | 5575.78% |
| BeiGene, Ltd. | -1.2 Billion USD | 223.549% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | 7583.462% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 406.28% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | 1693.292% |
| Erasca, Inc. | -141.52 Million USD | 1154.337% |
| bluebird bio, Inc. | -244.26 Million USD | 710.881% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | 33061.311% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | -667.405% |
| DBV Technologies S.A. | -76.43 Million USD | 2052.258% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | 33061.311% |
| Moderna, Inc. | -4.23 Billion USD | 135.201% |
| Vincerx Pharma, Inc. | -42.6 Million USD | 3601.96% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | 23561.478% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | 2319.239% |
| Travere Therapeutics, Inc. | -376.74 Million USD | 496.065% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | 1141.197% |
| Spruce Biosciences, Inc. | -51.99 Million USD | 2969.906% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | 1065.53% |
| Cogent Biosciences, Inc. | -208.13 Million USD | 816.932% |
| MacroGenics, Inc. | -168.24 Million USD | 986.896% |
| RenovoRx, Inc. | -11.39 Million USD | 13193.629% |
| Adicet Bio, Inc. | -152.03 Million USD | 1081.432% |
| Prime Medicine, Inc. | -191.29 Million USD | 880.038% |
| Aditxt, Inc. | -26.06 Million USD | 5825.292% |
| Adagene Inc. | -23.71 Million USD | 6390.719% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 20512.175% |
| Quantum-Si incorporated | -111.17 Million USD | 1442.212% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | 4814.832% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | 10335.792% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | -1122.933% |
| SciSparc Ltd. | -5.77 Million USD | 25947.047% |
| Vericel Corporation | -6.46 Million USD | 23184.004% |
| Revelation Biosciences, Inc. | -8.65 Million USD | 17337.01% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | 6554.054% |
| Generation Bio Co. | -138.56 Million USD | 1176.875% |
| Astria Therapeutics, Inc. | -83.03 Million USD | 1897.122% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | 1825.827% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | 718.89% |
| Invivyd, Inc. | -207.78 Million USD | 818.129% |
| Relay Therapeutics, Inc. | -373 Million USD | 500.04% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | 16010.32% |
| Spero Therapeutics, Inc. | 21.48 Million USD | -6846.371% |
| Artelo Biosciences, Inc. | -10.28 Million USD | 14605.201% |
| 2seventy bio, Inc. | -216.7 Million USD | 788.569% |
| ADMA Biologics, Inc. | 21.63 Million USD | -6797.883% |
| Clene Inc. | -40.54 Million USD | 3780.686% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | 6297.187% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | 2823.1% |
| GeoVax Labs, Inc. | -26.74 Million USD | 5679.604% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | 526.255% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | 4162.26% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | -9181.271% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | 1538.883% |
| Finch Therapeutics Group, Inc. | -34 Million USD | 4488.418% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | 976.302% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 318.053% |
| Evaxion Biotech A/S | -22.19 Million USD | 6822.305% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | 1911.257% |
| Verve Therapeutics, Inc. | -223.12 Million USD | 768.754% |
| Trevena, Inc. | -35.28 Million USD | 4328.491% |
| Surrozen, Inc. | -45.78 Million USD | 3359.393% |
| Tyra Biosciences, Inc. | -79.94 Million USD | 1966.471% |
| Cingulate Inc. | -22.75 Million USD | 6656.253% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | -19816.578% |
| Unity Biotechnology, Inc. | -44.66 Million USD | 3440.609% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | 18221.942% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | 1554.933% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | 2133.484% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | 2503.824% |
| Clearmind Medicine Inc. | -8.74 Million USD | 17170.018% |
| Kronos Bio, Inc. | -121.83 Million USD | 1324.78% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | 2058.305% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | 50974.791% |
| Viking Therapeutics, Inc. | -100.82 Million USD | 1579.911% |
| Statera Biopharma, Inc. | -98.34 Million USD | 1617.279% |
| ImmunityBio, Inc. | -362.25 Million USD | 511.912% |
| Korro Bio, Inc. | -84.53 Million USD | 1865.148% |
| Kineta, Inc. | -15.72 Million USD | 9590.237% |
| BioVie Inc. | -32.17 Million USD | 4736.946% |
| Codexis, Inc. | -68.06 Million USD | 2292.114% |
| Celularity Inc. | -192.28 Million USD | 876.001% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | 770.304% |
| Celcuity Inc. | -66.23 Million USD | 2352.971% |
| Virax Biolabs Group Limited | -6.49 Million USD | 23068.617% |
| Cibus, Inc. | -318.88 Million USD | 567.93% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | 3570.116% |
| IN8bio, Inc. | -30.33 Million USD | 5018.581% |
| Kodiak Sciences Inc. | -277.32 Million USD | 638.059% |
| Annexon, Inc. | -143.72 Million USD | 1138.212% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | 1305.378% |
| Assembly Biosciences, Inc. | -64.64 Million USD | 2408.186% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | 6464.742% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | 521.833% |
| Eyenovia, Inc. | -25.4 Million USD | 5973.116% |
| Puma Biotechnology, Inc. | 32.64 Million USD | -4471.538% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | 26927.58% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | 1985.623% |
| Arcellx, Inc. | -89.88 Million USD | 1760.158% |
| Cardiff Oncology, Inc. | -45.41 Million USD | 3385.806% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | 1187.517% |
| Regulus Therapeutics Inc. | -31.1 Million USD | 4896.522% |
| Moolec Science SA | -6.65 Million USD | 22525.514% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | 2540.626% |
| LAVA Therapeutics N.V. | -43.25 Million USD | 3549.819% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | 1008.95% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | 16096.692% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | 6915.131% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | 972.822% |
| Humacyte, Inc. | -100.04 Million USD | 1591.449% |
| 89bio, Inc. | -151.2 Million USD | 1086.846% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | 1962.115% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | 10362.38% |
| Genelux Corporation | -24.16 Million USD | 6274.84% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | 4498.638% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | 968.792% |
| Notable Labs, Ltd. | -14.65 Million USD | 10280.46% |
| Liquidia Corporation | -73.38 Million USD | 2133.345% |
| Mustang Bio, Inc. | -50.72 Million USD | 3041.588% |
| Immunovant, Inc. | -282.7 Million USD | 627.804% |
| Quantum-Si incorporated | -111.17 Million USD | 1442.212% |
| Arbutus Biopharma Corporation | -78.1 Million USD | 2010.49% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | 7116.269% |
| Vera Therapeutics, Inc. | -102.01 Million USD | 1562.72% |
| Acasti Pharma Inc. | -11.31 Million USD | 13290.859% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | 6609.939% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | 9437.983% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | 797.09% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | 40768.322% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | 9492.862% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | 5217.639% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | 3705.621% |
| PepGen Inc. | -84.76 Million USD | 1860.317% |
| Moleculin Biotech, Inc. | -29.63 Million USD | 5135.773% |
| United Therapeutics Corporation | 1.18 Billion USD | -25.93% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 6616.793% |
| Solid Biosciences Inc. | -104.31 Million USD | 1530.427% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | 4648.112% |
| Immuneering Corporation | -58.41 Million USD | 2654.488% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | 29413.965% |
| Silo Pharma, Inc. | -3.85 Million USD | 38800.931% |
| Belite Bio, Inc | -31.66 Million USD | 4811.854% |
| XOMA Corporation | -41.84 Million USD | 3665.642% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | 2309.938% |
| Bionomics Limited | -17.89 Billion USD | 108.34% |
| Apogee Therapeutics, Inc. | -93 Million USD | 1704.411% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | -4082.035% |
| uniQure N.V. | -282.87 Million USD | 627.502% |
| Cassava Sciences, Inc. | -105.95 Million USD | 1508.26% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | 20512.175% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | 1252.204% |
| Forte Biosciences, Inc. | -32.48 Million USD | 4693.21% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | 18058.768% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | 5176.203% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | 26927.58% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | 10600.704% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | 16886.478% |
| Altimmune, Inc. | -95.92 Million USD | 1655.473% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | 2130.302% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | -4082.035% |
| Compugen Ltd. | -12.99 Million USD | 11585.145% |
| Peak Bio, Inc. | -1356.23 USD | 110021998.94% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | 3108.124% |
| Benitec Biopharma Inc. | -22.49 Million USD | 6734.727% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 715.82% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | 5116.305% |
| Zura Bio Limited | -62.63 Million USD | 2482.18% |
| PolyPid Ltd. | -22.86 Million USD | 6625.342% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | 9267.793% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | 5116.305% |
| Instil Bio, Inc. | -159.16 Million USD | 1037.463% |
| argenx SE | -425.04 Million USD | 451.054% |
| Immunome, Inc. | -109.53 Million USD | 1462.321% |
| Compass Therapeutics, Inc. | -50.36 Million USD | 3062.79% |
| Verona Pharma plc | -67.83 Million USD | 2299.809% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | 5825.825% |
| Shattuck Labs, Inc. | -91.95 Million USD | 1722.661% |
| CervoMed Inc. | -7.81 Million USD | 19198.554% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | 2140.966% |
| Plus Therapeutics, Inc. | -13.32 Million USD | 11301.486% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | 3197.418% |
| Moolec Science SA | -6.65 Million USD | 22525.514% |
| Enveric Biosciences, Inc. | -16.44 Million USD | 9171.681% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | 1203.444% |
| Design Therapeutics, Inc. | -78.19 Million USD | 2008.364% |
| Leap Therapeutics, Inc. | -87.04 Million USD | 1814.307% |
| NeurAxis, Inc. | -6.66 Million USD | 22489.543% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | 3784.412% |
| Lumos Pharma, Inc. | -36.61 Million USD | 4175.354% |
| Achilles Therapeutics plc | -75.25 Million USD | 2082.792% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | 5825.825% |
| 180 Life Sciences Corp. | -13.47 Million USD | 11171.415% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | -28838.324% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | 50974.791% |
| Nutriband Inc. | -4.87 Million USD | 30727.518% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | 1446.949% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | 2791.031% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | 3035.223% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | 2357.447% |
| MoonLake Immunotherapeutics | -54.12 Million USD | 2856.956% |
| Palisade Bio, Inc. | -13.07 Million USD | 11516.603% |
| Tourmaline Bio, Inc. | -45.4 Million USD | 3386.023% |
| Beam Therapeutics Inc. | -176.48 Million USD | 945.483% |
| Neurogene Inc. | -55.58 Million USD | 2784.544% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | 1467.014% |
| AEON Biopharma, Inc. | -48.42 Million USD | 3181.108% |
| Sesen Bio, Inc. | -25.9 Million USD | 5859.196% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | 1886.386% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | 11954.789% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 423.987% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | 2159.871% |
| Athira Pharma, Inc. | -125.46 Million USD | 1289.286% |
| Vaccinex, Inc. | -22.88 Million USD | 6620.21% |
| HCW Biologics Inc. | -25.71 Million USD | 5902.157% |
| XOMA Corporation | -41.84 Million USD | 3665.642% |
| Nektar Therapeutics | -137.42 Million USD | 1185.792% |
| Arvinas, Inc. | -401.5 Million USD | 471.644% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | 16873841.24% |
| Merus N.V. | -156.54 Million USD | 1053.164% |
| Omega Therapeutics, Inc. | -100.26 Million USD | 1588.266% |
| Quince Therapeutics, Inc. | -34.62 Million USD | 4410.081% |
| Rezolute, Inc. | -70.42 Million USD | 2218.839% |
| Clene Inc. | -40.54 Million USD | 3780.686% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | 9210.434% |
| BeyondSpring Inc. | -23.11 Million USD | 6555.611% |
| Synlogic, Inc. | -55.16 Million USD | 2805.081% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | 8422.55% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | 13885.569% |
| Peak Bio, Inc. | -1356.23 USD | 110021998.94% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | 3784.048% |
| Krystal Biotech, Inc. | -109.72 Million USD | 1459.875% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | 1251.884% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | 535.013% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | 31540.471% |
| MannKind Corporation | 8.67 Million USD | -17094.63% |
| Ikena Oncology, Inc. | -75.41 Million USD | 2078.533% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | 15567.503% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | 2319.47% |
| Gossamer Bio, Inc. | -183.75 Million USD | 912.015% |
| CohBar, Inc. | -12.38 Million USD | 12144.836% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | 3041.704% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | 5508.888% |
| Legend Biotech Corporation | -439.48 Million USD | 439.522% |
| Mural Oncology plc | -194.63 Million USD | 866.628% |
| Biora Therapeutics, Inc. | -67.14 Million USD | 2322.346% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | 9342.026% |
| Disc Medicine, Inc. | -91.12 Million USD | 1737.476% |
| Champions Oncology, Inc. | -7.35 Million USD | 20384.802% |
| REGENXBIO Inc. | -268.12 Million USD | 656.507% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | 14021.664% |
| Anavex Life Sciences Corp. | -55.75 Million USD | 2776.214% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | 3929.891% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | 1404.817% |
| Vaxart, Inc. | -83.34 Million USD | 1890.286% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | 17613.481% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | 3586.814% |
| Cellectis S.A. | -106.62 Million USD | 1499.424% |
| Longeveron Inc. | -21.02 Million USD | 7195.677% |
| Repare Therapeutics Inc. | -116.22 Million USD | 1383.857% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | 657.138% |
| Inozyme Pharma, Inc. | -75.64 Million USD | 2072.569% |
| Revolution Medicines, Inc. | -487.18 Million USD | 406.28% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | 22531.6% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | 3494.799% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | 2100.469% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | 2242.816% |
| Anixa Biosciences, Inc. | -11.01 Million USD | 13651.449% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 65.359% |
| Denali Therapeutics Inc. | -196.69 Million USD | 858.596% |
| Revelation Biosciences, Inc. | -8.65 Million USD | 17337.01% |
| Veru Inc. | -93.78 Million USD | 1691.08% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | 6496.116% |
| Cingulate Inc. | -22.75 Million USD | 6656.253% |
| Passage Bio, Inc. | -108.38 Million USD | 1476.662% |
| Context Therapeutics Inc. | -25.07 Million USD | 6051.314% |
| Exicure, Inc. | -14.99 Million USD | 10050.32% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 824.12% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | 3775.427% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | 15456.177% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | 909.381% |
| Nuvalent, Inc. | -149.49 Million USD | 1098.147% |
| ABVC BioPharma, Inc. | -8.21 Million USD | 18260.389% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | 1781.656% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | 7282.777% |
| OmniAb, Inc. | -69.41 Million USD | 2249.484% |
| Anew Medical, Inc. | -1.3 Million USD | 114806.651% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | 11783.893% |
| Lipocine Inc. | -17.93 Million USD | 8421.642% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | 2277.908% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | 2059.436% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | 4018.943% |
| G1 Therapeutics, Inc. | -39.52 Million USD | 3875.015% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | 6766.145% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 357.334% |
| Ocugen, Inc. | -65.53 Million USD | 2377.014% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | 1689.66% |
| Q32 Bio Inc. | -92.1 Million USD | 1720.106% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | 7059.979% |
| Alumis Inc. Common Stock | -158.17 Million USD | 1043.36% |
| Equillium, Inc. | -14.52 Million USD | 10375.1% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | 2491.036% |
| Coya Therapeutics, Inc. | -7.9 Million USD | 18979.971% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | 8009.576% |
| Galera Therapeutics, Inc. | -46.95 Million USD | 3278.101% |
| Evelo Biosciences, Inc. | -108.46 Million USD | 1475.685% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | 12565.732% |
| Dominari Holdings Inc. | -21.79 Million USD | 6945.981% |
| Edesa Biotech, Inc. | -9.22 Million USD | 16279.0% |
| vTv Therapeutics Inc. | -25.5 Million USD | 5951.11% |
| Bio-Techne Corporation | 206.68 Million USD | -621.941% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 481.149% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | -677.04% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | 1228.049% |
| Candel Therapeutics, Inc. | -38.39 Million USD | 3986.718% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | 1087.518% |
| Nkarta, Inc. | -131.65 Million USD | 1233.422% |
| BioCardia, Inc. | -11.64 Million USD | 12914.754% |
| Iterum Therapeutics plc | -47.46 Million USD | 3243.486% |